Cargando…
MicroRNA调控肿瘤耐药的研究进展
Chemotherapy is one of the primary treatment for malignant tumors. Tumor multidrug resistance (MDR) is a major cause of clinical failure of chemotherapy; however the mechanisms of chemo-resistance have not been fully elucidated. Recently, microRNA is one of the new hotspots in life science. MicroRNA...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000396/ https://www.ncbi.nlm.nih.gov/pubmed/25342041 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.10.06 |
Ejemplares similares
-
P21参与肺癌耐药的研究进展
Publicado: (2020) -
骨桥蛋白及其受体CD44v对肿瘤侵袭调控的研究进展
Publicado: (2015) -
MicroRNA与肺癌顺铂耐药相关性研究进展
Publicado: (2014) -
EGFR突变调控肺腺癌PD-L1表达的分子机制研究进展
Publicado: (2018) -
肿瘤侵袭转移相关microRNAs的研究进展
Publicado: (2010)